AHeDD2019/IPAB2019 Joint Symposium

Trends in Artificial Intelligence and Molecular Simulation for Accelerating e-Drug Discovery

The symposium has finished. A total of 105 people attended this year. Thank you very much for joining!

AHeDD2019/IPAB2019 Joint Symposium Group Photo (Nov 28, 2019)
AHeDD2019/IPAB2019 Joint Symposium Group Photo (Nov 29, 2019)

It is our great pleasure to announce that AHeDD2019/IPAB2019 Joint Symposium will be held at Tonomachi King Skyfront area, LiSE and PeptiDream Inc., Kawasaki-City, Kanagawa, Japan, during November 27-29, 2019.

The scientists of China, Japan, and Korea working in the fields of Computer-Aided Drug Design, Computational Biology, and High-Performance Computing agreed with to establish a meeting, Asia Hub for e-Drug Discovery (AHeDD).

The 1st AHeDD meeting was held in 2005 at Jeju Island of Korea. Then continued to have meetings 2006 (Seoul), 2007 (Shanghai), 2008 (Tokyo with IPAB), 2009 (Busan with KBSI-CBI), 2010 (Seoul-Yonsei University), 2014 (Chengdu), 2017 (Melbourne with RACI), 2018 (KIST, Gangneung), and 2019 (King Skyfront, Kawasaki).

AHeDD is not a meeting like an academic society but a meeting based on scholarship and friendship among members.

We are looking forward to seeing you in AHeDD2019/IPAB2019 Joint Symposium, Kawasaki-city, Japan.

AHeDD2019/IPAB2019 Joint Symposium Chair,
Yutaka Akiyama.